Commodore Capital LP 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 4:05 pm Purchase |
2025-04-03 | 13G | Celldex Therapeutics, Inc. CLDX |
Commodore Capital LP | 3,350,000 5.000% |
3,350,000 (New Position) |
Filing |